Balyasny Asset Management »

Biosante Pharmaceuticals shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Biosante Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Biosante Pharmaceuticals held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biosante Pharmaceuticals by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $2.1M 39k 55.54
2024-06-30 $767k 12k 63.68
2023-12-31 $293k 5.3k 55.14
2022-09-30 $4.5M 139k 32.14
2015-06-30 $480k 7.7k 62.10

More positions owned by Balyasny Asset Management

Ishares Tr Russell 2000 Etf (IWM)
Apple (AAPL)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Select Sector Spdr Tr Financial (XLF)
NVIDIA Corporation Call Option (NVDA)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Select Sector Spdr Tr Energy (XLE)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Select Sector Spdr Tr Sbi Cons Discr (XLY)
salesforce Call Option (CRM)
Home Depot Call Option (HD)
Taiwan Semiconductor Mfg Sponsored Ads Call Option (TSM)

View all positions for Balyasny Asset Management

Top funds holding Biosante Pharmaceuticals

BlackRock
Vanguard Group
Millennium Management
State Street Corporation
Goldman Sachs Group
Dimensional Fund Advisors
Global Alpha Capital Management
Citadel Advisors
UBS Group
Ranger Investment Management
Macquarie Group
Deep Track Capital
William Blair Investment Management
Geode Capital Management
Tang Capital Management

View all funds holding Biosante Pharmaceuticals